Level D· Scientific groundwork from lab and animal studiesNarrative ReviewPubMedOpen access

Adipose Stem Cell Translational Applications: From Bench-to-Bedside.

Argentati C., Morena F., Bazzucchi M., Armentano I., Emiliani C., Martino S.

Narrative Review, published in Int J Mol Sci (2018) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Int J Mol Sci (2018)
Country
Switzerland
Reported sample size
—
Source database
PubMed
PMID
30400641
PMCID
PMC6275042
DOI
10.3390/ijms19113475
NCT
NCT01532076
Citations
67

Abstract (original English)

During the last five years, there has been a significantly increasing interest in adult adipose stem cells (ASCs) as a suitable tool for translational medicine applications. The abundant and renewable source of ASCs and the relatively simple procedure for cell isolation are only some of the reasons for this success. Here, we document the advances in the biology and in the innovative biotechnological applications of ASCs. We discuss how the multipotential property boosts ASCs toward mesenchymal and non-mesenchymal differentiation cell lineages and how their character is maintained even if they are combined with gene delivery systems and/or biomaterials, both in vitro and in vivo.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Adipose TissueAnimalsClinical Trials as TopicHumansRegenerative MedicineStem CellsTissue EngineeringTranslational Research, Biomedical

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.